House File 852 - Introduced



                                       HOUSE FILE       
                                       BY  COMMITTEE ON PUBLIC SAFETY

                                       (SUCCESSOR TO HSB 216)


    Passed House, Date               Passed Senate,  Date             
    Vote:  Ayes        Nays           Vote:  Ayes        Nays         
                 Approved                            

                                      A BILL FOR

  1 An Act relating to the sale of a pseudoephedrine product by a
  2    pharmacy or retailer, and providing penalties and contingent
  3    applicability.
  4 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
  5 TLSB 1286HV 82
  6 jm/gg/14

PAG LIN



  1  1    Section 1.  Section 124.212, subsection 4, paragraph c,
  1  2 Code 2007, is amended to read as follows:
  1  3    c.  Pseudoephedrine.  A person shall present a
  1  4 government=issued driver's license or other state=issued photo
  1  5 identification card when purchasing a pseudoephedrine product
  1  6 from a pharmacy.  A person shall not purchase more than seven
  1  7 thousand five hundred milligrams of pseudoephedrine, either
  1  8 separately or collectively, within a thirty=day period a
  1  9 quantity of pseudoephedrine in violation of section 124.213
  1 10 from a pharmacy, unless the person has a prescription for a
  1 11 pseudoephedrine product in excess of that quantity.  A
  1 12 pseudoephedrine product not excepted from this schedule shall
  1 13 be sold by a pharmacy as provided in section 124.212A.
  1 14    Sec. 2.  NEW SECTION.  124.212A  PHARMACY PSEUDOEPHEDRINE
  1 15 SALE == RESTRICTIONS == RECORDS == CONTINGENT APPLICABILITY.
  1 16    1.  A pharmacy, an employee of a pharmacy, or a licensed
  1 17 pharmacist shall do the following:
  1 18    a.  Provide for the sale of a pseudoephedrine product in a
  1 19 locked cabinet or behind the sales counter where the public is
  1 20 unable to reach the product and where the public is not
  1 21 permitted.
  1 22    b.  Require the purchaser to present a driver's license or
  1 23 other state=issued photo identification card identifying the
  1 24 purchaser prior to purchasing a pseudoephedrine product.
  1 25    c.  Provide an electronic logbook for purchasers of
  1 26 pseudoephedrine products to sign.
  1 27    d.  Require the purchaser to sign the electronic logbook.
  1 28 If the electronic logbook is not available, require a
  1 29 signature that is associated with a transaction number.
  1 30    e.  Enter the purchaser's name, address, date of purchase,
  1 31 time of purchase, name of the pseudoephedrine product
  1 32 purchased, and the quantity sold in the electronic logbook.
  1 33 If the electronic logbook is unavailable, an alternative
  1 34 record shall be kept that complies with rules adopted by the
  1 35 board.
  2  1    f.  Determine that the signature in the electronic logbook
  2  2 corresponds with the name on the driver's license or other
  2  3 state=issued photo identification card.
  2  4    g.  Provide notice that a purchaser entering a false
  2  5 statement or misrepresentation in the electronic logbook may
  2  6 subject the purchaser to criminal penalties under 18 U.S.C. }
  2  7 1001.
  2  8    h.  Keep electronic logbook records and any other records
  2  9 obtained if the electronic logbook is unavailable for
  2 10 twenty=four months from the date of the last entry.
  2 11    i.  Disclose electronic logbook information and any other
  2 12 associated records as provided by state and federal law.
  2 13    j.  Comply with training requirements pursuant to federal
  2 14 law.
  2 15    2.  This section is not applicable unless sufficient
  2 16 funding is received to implement the statewide real=time
  2 17 central repository and the board establishes the statewide
  2 18 real=time central repository.  However, subsection 1,
  2 19 paragraph "h" is applicable upon the effective date of this
  2 20 Act.
  2 21    Sec. 3.  NEW SECTION.  124.212B  PSEUDOEPHEDRINE SALES ==
  2 22 TRACKING == PENALTY == CONTINGENT APPLICABILITY.
  2 23    1.  The board shall establish a real=time electronic
  2 24 repository to monitor and control the sale of schedule V
  2 25 products containing any detectible amount of pseudoephedrine,
  2 26 its salts, or optical isomers, or salts of optical isomers;
  2 27 ephedrine; or phenylpropanolamine.  A pharmacy dispensing such
  2 28 products shall report all such sales electronically to a
  2 29 central repository under the control of the board.
  2 30    2.  The information collected in the central repository is
  2 31 confidential unless otherwise ordered by a court, or released
  2 32 by the lawful custodian of the records pursuant to this
  2 33 section.
  2 34    3.  A pharmacy, an employee of a pharmacy, or a licensed
  2 35 pharmacist shall not be provided access to the stored
  3  1 information in the electronic central repository, except for
  3  2 the purpose of obtaining sufficient information for the
  3  3 pharmacist to determine whether to complete the sale of the
  3  4 product.  A pharmacy, an employee of a pharmacy, or a licensed
  3  5 pharmacist shall not be given the obligation or duty to view
  3  6 the stored information.
  3  7    4.  A pharmacy, or an employee of a pharmacy, or a licensed
  3  8 pharmacist shall not be given the obligation or duty to seek
  3  9 information from the central repository if the real=time
  3 10 electronic logbook becomes unavailable for use.
  3 11    5.  If the electronic logbook is unavailable for use, a
  3 12 paper record for each sale shall be maintained including the
  3 13 purchaser's signature.  Any paper record maintained by the
  3 14 pharmacy shall be provided to the board for inclusion in the
  3 15 electronic real=time central repository as soon as
  3 16 practicable.
  3 17    6.  A pharmacy, or an employee of a pharmacy, or a licensed
  3 18 pharmacist shall not be liable to any person for any claim
  3 19 which may arise when reporting sales of products enumerated in
  3 20 subsection 1 to the central repository.
  3 21    7.  A person who discloses information stored in the
  3 22 central repository in violation of this section commits a
  3 23 simple misdemeanor.
  3 24    8.  The board shall adopt rules to administer this section.
  3 25    9.  This section is not applicable unless sufficient
  3 26 funding is received to implement this section and the board
  3 27 establishes the statewide real=time central repository.
  3 28    Sec. 4.  NEW SECTION.  124.212C  PSEUDOEPHEDRINE ADVISORY
  3 29 COUNCIL == ELECTRONIC MONITORING.
  3 30    1.  The board shall establish a pseudoephedrine advisory
  3 31 council to provide input and advise the board regarding the
  3 32 implementation of the statewide real=time central repository
  3 33 established under section 124.212B to monitor sales of
  3 34 pseudoephedrine.  The board shall specify the duties,
  3 35 responsibilities, and other related matters of the advisory
  4  1 council.
  4  2    2.  The council shall consist of four licensed pharmacists.
  4  3 The board shall solicit recommendations for membership on the
  4  4 council from the Iowa pharmacy association and shall appoint
  4  5 members from the recommendations.  The council shall include a
  4  6 member from an independent pharmacy, a member from a regional
  4  7 chain pharmacy, and a member from a national chain pharmacy.
  4  8 The license of any member must be current and not subject to
  4  9 disciplinary sanctions.
  4 10    3.  The council may make recommendations regarding the
  4 11 implementation of the statewide real=time central repository
  4 12 monitoring system under section 124.212B.
  4 13    4.  The council shall do the following:
  4 14    a.  Assist the board in implementing the statewide
  4 15 real=time central repository monitoring system.
  4 16    b.  Assist the board in developing utilization guidance
  4 17 related to the statewide real=time central repository
  4 18 monitoring system and disseminating such guidance.
  4 19    c.  Assist the board in developing guidelines to ensure
  4 20 patient confidentiality and the integrity of the relationship
  4 21 established by the patient and the patient's health care
  4 22 provider.
  4 23    5.  Each member of the council shall receive per diem
  4 24 compensation at the rate specified in section 7E.6 for each
  4 25 day spent in the performance of the member's duties.  All
  4 26 members of the council shall receive actual and necessary
  4 27 expenses incurred in the performance of their duties.
  4 28    6.  This section is repealed when the establishment of the
  4 29 statewide real=time central repository is complete.
  4 30    Sec. 5.  Section 124.213, Code 2007, is amended by striking
  4 31 the section and inserting in lieu thereof the following:
  4 32    124.213  PSEUDOEPHEDRINE PURCHASE RESTRICTIONS FROM
  4 33 PHARMACY OR RETAILER == PENALTY.
  4 34    1.  A person shall not purchase more than three thousand
  4 35 six hundred milligrams of pseudoephedrine, either separately
  5  1 or collectively, within a twenty=four=hour period from a
  5  2 pharmacy, or more than one package of a product containing
  5  3 pseudoephedrine within a twenty=four hour period from a
  5  4 retailer in violation of section 126.23A.
  5  5    2.  A person shall not purchase more than seven thousand
  5  6 five hundred milligrams of pseudoephedrine, either separately
  5  7 or collectively, within a thirty=day period from a pharmacy or
  5  8 from a retailer in violation of section 126.23A.
  5  9    3.  A person who violates this section commits a serious
  5 10 misdemeanor.
  5 11    Sec. 6.  Section 126.23A, subsection 1, paragraph a,
  5 12 subparagraph (1), Code 2007, is amended by striking the
  5 13 subparagraph and inserting in lieu thereof the following:
  5 14    (1)  Sell more than seven thousand five hundred milligrams
  5 15 of pseudoephedrine to the same person within a thirty=day
  5 16 period.
  5 17    Sec. 7.  Section 126.23A, subsection 1, paragraph b, Code
  5 18 2007, is amended to read as follows:
  5 19    b.  A retailer or an employee of a retailer shall do the
  5 20 following:
  5 21    (1)  Provide for the sale of a pseudoephedrine product in a
  5 22 locked cabinet or behind a sales counter where the public is
  5 23 unable to reach the product and where the public is not
  5 24 permitted.
  5 25    (2)  Require a purchaser to present a government=issued
  5 26 photo driver's license or other state=issued photo
  5 27 identification card identifying the purchaser prior to
  5 28 purchasing a pseudoephedrine product.
  5 29    (3)  Require the purchaser to sign a logbook and to also
  5 30 require the purchaser to legibly print the purchaser's name
  5 31 and address in the logbook.
  5 32    (4)  Print the name of the pseudoephedrine product
  5 33 purchased and quantity sold next to the name of each purchaser
  5 34 in the logbook.
  5 35    (4)  (5)  Determine the signature in the logbook
  6  1 corresponds with the name on the government=issued photo
  6  2 driver's license or other state=issued photo identification
  6  3 card.
  6  4    (5)  (6)  Keep the logbook twelve twenty=four months from
  6  5 the date of the last entry.
  6  6    (6)  (7)  Provide notification in a clear and conspicuous
  6  7 manner in a location where a pseudoephedrine product is
  6  8 offered for sale stating the following:
  6  9    Iowa law prohibits the over=the=counter purchase of more
  6 10 than one package of a product containing pseudoephedrine in a
  6 11 twenty=four=hour period or of more than seven thousand five
  6 12 hundred milligrams of pseudoephedrine within a thirty=day
  6 13 period.  If you purchase a product containing pseudoephedrine,
  6 14 you are required to sign a logbook which may be accessible to
  6 15 law enforcement officers.
  6 16    (8)  Provide notification affixed to the logbook stating
  6 17 that a purchaser entering a false statement or
  6 18 misrepresentation in the logbook may subject the purchaser to
  6 19 criminal penalties under 18 U.S.C. } 1001.
  6 20    (9)  Disclose logbook information as provided by state and
  6 21 federal law.
  6 22    (10)  Comply with training requirements pursuant to federal
  6 23 law.
  6 24    Sec. 8.  CONTINGENT APPLICABILITY == PHARMACY BOARD AND
  6 25 CODE EDITOR RESPONSIBILITIES.
  6 26    1.  The board of pharmacy examiners shall notify the Code
  6 27 editor when the establishment of the repository on a statewide
  6 28 basis is complete.
  6 29    2.  When the establishment of the central repository on a
  6 30 statewide basis is complete, the Code editor is directed to
  6 31 remove section 124.212A, subsection 2, section 124.212B,
  6 32 subsection 9, and section 124.212C, from the Code and to
  6 33 internally renumber the sections as necessary.
  6 34                           EXPLANATION
  6 35    This bill relates to the sale of a pseudoephedrine product
  7  1 by a pharmacy or retailer.
  7  2    PENALTIES.  The bill provides that a person shall not
  7  3 purchase more than 3,600 milligrams of pseudoephedrine, either
  7  4 collectively or separately, within a 24=hour period from a
  7  5 pharmacy unless the person has a prescription.  A person who
  7  6 violates this provision of the bill commits a serious
  7  7 misdemeanor.  Under current law and the bill, a person commits
  7  8 a serious misdemeanor if the person purchases more than 7,500
  7  9 milligrams of pseudoephedrine within a 30=day period from a
  7 10 pharmacy or retailer.
  7 11    PHARMACY.  The bill requires a purchaser of a
  7 12 pseudoephedrine product from a pharmacy to present a driver's
  7 13 license or other state=issued photo identification card prior
  7 14 to purchase, and sign an electronic logbook.  Current law does
  7 15 not require an electronic logbook and requires a purchaser to
  7 16 present a government=issued photo identification card prior to
  7 17 purchase.  The bill also provides that if the electronic
  7 18 logbook is unavailable, the pharmacy is required to keep an
  7 19 alternative record that complies with rules adopted by the
  7 20 state board of pharmacy examiners.
  7 21    The bill requires a pharmacy, an employee of a pharmacy, or
  7 22 a licensed pharmacist, to enter a purchaser's name, address,
  7 23 date of purchase, time of purchase, name of pseudoephedrine
  7 24 product, and quantity sold into an electronic logbook.  If the
  7 25 electronic logbook is unavailable for use, the bill requires
  7 26 the pharmacy to keep written records of the transaction
  7 27 including a signature.
  7 28    The bill requires a pharmacy to keep electronic logbook
  7 29 records for a period of 24 months from the date of the last
  7 30 entry.  Current law requires the pharmacy to keep the logbook
  7 31 12 months from the date of the last entry.
  7 32    The bill provides that the state board of pharmacy
  7 33 examiners shall implement a statewide real=time central
  7 34 repository to track pseudoephedrine product sales at
  7 35 pharmacies.  The bill requires a pharmacy dispensing
  8  1 pseudoephedrine products to report all such sales
  8  2 electronically to the central repository under the control of
  8  3 the state board of pharmacy examiners.  If the pharmacy has
  8  4 written records, the records are also to be reported for entry
  8  5 into the repository.  If the electronic logbook is unavailable
  8  6 for use, the bill requires the pharmacy to keep written
  8  7 records of the transaction including a signature.
  8  8    The bill makes confidential the information collected in
  8  9 the central repository unless otherwise ordered by a court, or
  8 10 the records are released by the custodian of the records
  8 11 pursuant to new Code section 124.212B.
  8 12    The bill provides that a pharmacy, an employee of a
  8 13 pharmacy, or a licensed pharmacist shall not be liable to any
  8 14 person for any claim which may arise when reporting
  8 15 pseudoephedrine sales to the central repository.
  8 16    The bill also requires a pharmacy to comply with training
  8 17 requirements pursuant to federal law.
  8 18    A person who discloses information stored in the central
  8 19 repository in violation of the bill commits a simple
  8 20 misdemeanor.
  8 21    RETAILER.  The bill requires a purchaser of a
  8 22 pseudoephedrine product from a retailer to present a driver's
  8 23 license or other state=issued photo identification card prior
  8 24 to purchase.  Current law requires a purchaser to present a
  8 25 government=issued photo identification card prior to purchase.
  8 26    The bill requires a retailer or an employee of a retailer
  8 27 to print the name of the pseudoephedrine product purchased and
  8 28 the quantity sold next to the name of each purchaser in the
  8 29 logbook.
  8 30    The bill requires the retailer to keep the logbook 24
  8 31 months from the date of the last entry.  Current law requires
  8 32 the retailer to keep the logbook 12 months from the date of
  8 33 the last entry.  The bill does not require a retailer to keep
  8 34 an electronic logbook of pseudoephedrine purchases.
  8 35    The bill also requires a retailer to comply with training
  9  1 requirements pursuant to federal law.
  9  2    ADVISORY COMMITTEE.  The bill requires the board of
  9  3 pharmacy examiners to establish a pseudoephedrine advisory
  9  4 committee to provide input and advise the board regarding the
  9  5 implementation of the statewide real=time central repository.
  9  6 The advisory committee shall consist of four licensed
  9  7 pharmacists including a pharmacist from an independent
  9  8 pharmacy, a regional chain pharmacy, and a national chain
  9  9 pharmacy.  Code section 124.212C establishing the advisory
  9 10 committee is repealed when the establishment of the statewide
  9 11 real=time repository is complete.
  9 12    CONTINGENT APPLICABILITY.  New Code sections 124.212A and
  9 13 124.212B created in the bill do not become applicable until
  9 14 sufficient funding is received and the central repository
  9 15 under the control of the state board of pharmacy examiners is
  9 16 established on a statewide basis.  However, Code section
  9 17 124.212A, subsection 1, paragraph "h", in the bill, which
  9 18 requires a pharmacy to keep logbook records 24 months from the
  9 19 date of the last entry, is applicable upon the effective date
  9 20 of the bill.
  9 21 LSB 1286HV 82
  9 22 jm:rj/gg/14